The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
IGNITE: A phase II signal-seeking trial of adavosertib targeting recurrent high-grade, serous ovarian cancer with cyclin E1 overexpression with and without gene amplification.
 
George Au-Yeung
Research Funding - AstraZeneca (Inst); Roche/Genentech (Inst)
 
Mathias Bressel
No Relationships to Disclose
 
Owen Prall
No Relationships to Disclose
 
Daniela Surace
No Relationships to Disclose
 
John Andrews
No Relationships to Disclose
 
Sally Mongta
No Relationships to Disclose
 
Yeh Chen Lee
Consulting or Advisory Role - GlaxoSmithKline
Research Funding - AstraZeneca (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Bo Gao
Consulting or Advisory Role - BeiGene; MSD
 
Tarek Meniawy
Honoraria - AstraZeneca/MedImmune
Consulting or Advisory Role - AstraZeneca/MedImmune; BMS; GlaxoSmithKline; Novartis
Research Funding - AstraZeneca/MedImmune (Inst); Bayer (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); Merck Serono (Inst); Regeneron (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - BMS
 
Sally E. Baron-Hay
Consulting or Advisory Role - AstraZeneca; Eisai; GlaxoSmithKline; Merck Sharpe and Doehme; Novartis
 
Allison Jane Black
Honoraria - AstraZeneca/MedImmune
Consulting or Advisory Role - AstraZeneca/MedImmune
 
Ganessan Kichenadasse
No Relationships to Disclose
 
Sumitra Ananda
No Relationships to Disclose
 
Peter Fox
No Relationships to Disclose
 
David Bowtell
Honoraria - AstraZeneca
Consulting or Advisory Role - Exo Therapeutics
Research Funding - AstraZeneca; BeiGene; Roche/Genentech
Patents, Royalties, Other Intellectual Property - Astra Zeneca Genentech Roche
 
Linda R. Mileshkin
No Relationships to Disclose